Equity Overview
Price & Market Data
Price: $2.90
Daily Change: +$0.08 / 2.76%
Daily Range: $2.82 - $2.94
Market Cap: $13,612,583
Daily Volume: 5,591
Performance Metrics
1 Week: -0.68%
1 Month: 1.75%
3 Months: -9.66%
6 Months: -21.62%
1 Year: -25.26%
YTD: 4.69%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.